Company Filing History:
1 out of 16 
1 out of 2 Years Active: 2024
Title: Fang-Wei Tien: Innovator in Pharmaceutical Formulations
Introduction
Fang-Wei Tien is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy of medications through advanced formulations.
Latest Patents
Fang-Wei Tien holds a patent for an "Amorphous solid dispersion formulation." This patent describes an amorphous solid dispersion that contains a Cap-dependent endonuclease inhibitor or a pharmaceutically acceptable salt thereof for oral administration. The formulation is designed to improve the delivery of the active ingredient, which is dispersed in a matrix formed from a pharmaceutically acceptable polymer. The patent also outlines methods for preparing this amorphous solid dispersion and its use in treating viral infections, along with a pharmaceutical composition containing the same.
Career Highlights
Throughout his career, Fang-Wei Tien has worked with various companies, including Taigen Biotechnology Company, Ltd. and Taigen Biopharmaceuticals Co. (Beijing), Ltd. His experience in these organizations has allowed him to contribute to the advancement of biopharmaceuticals and innovative drug delivery systems.
Collaborations
Fang-Wei Tien has collaborated with Chi-Feng Yen, a fellow professional in the field. Their partnership has likely fostered advancements in pharmaceutical research and development.
Conclusion
Fang-Wei Tien's contributions to pharmaceutical formulations, particularly through his patented innovations, highlight his role as a key inventor in the industry. His work continues to influence the development of effective treatments for viral infections.